Solid Biosciences  logo
Solid Biosciences SLDB
$ 5.69 -1.13%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Solid Biosciences Financial Statements 2011-2024 | SLDB

Annual Financial Statements Solid Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

243 M 38.6 M 12.5 M 26.2 M 136 M 846 M 725 M - - - - - -

Shares

19.9 M 8.51 M 7.12 M 3.46 M 40.3 M 33.3 M 32.2 M - - - - - -

Historical Prices

12.2 4.53 1.75 7.58 4.45 26.8 - - - - - - -

Net Income

-96 M -86 M -72.2 M -88.3 M -117 M -74.8 M -52.1 M -21.5 M -6.38 M - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-104 M -106 M -72.3 M -88.4 M -119 M -75.7 M -54.9 M -25.6 M - - - - -

Interest Expense

1.1 M -381 K 2 K 1 K 515 K 270 K 1 M 271 K - - - - -

EBITDA

-102 M -104 M -69.3 M -84.5 M -116 M -74.1 M -54.4 M -25.5 M -6.56 M - - - -

Operating Expenses

104 M 115 M 85.9 M 88.4 M 119 M 75.7 M - - - - - - -

General and Administrative Expenses

27.8 M 28.9 M 27.1 M 21.6 M 24.6 M 17.7 M 15 M 5.46 M 2.37 M - - - -

All numbers in USD currency

Quarterly Income Statement Solid Biosciences

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

40.9 M 38.2 M 20.4 M 20.1 M 19.7 M 19.6 M 19.6 M 7.53 M 7.52 M 7.51 M 7.36 M 7.49 M 112 M 89.3 M 84.9 M 48.3 M 48.2 M 48.1 M 46 M 43.5 M 34.8 M 34.8 M 35.4 M 34.5 M 34.4 M 29.4 M - 17.1 M 17 M 3.05 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-25.1 M -24.3 M - -21 M -24.6 M -30.1 M - -20.4 M -25.1 M -25.3 M - -18 M -18.7 M -16.9 M - -21.2 M -19 M -26.7 M -31.9 M -29.3 M -26.5 M -29.6 M -21.9 M -19 M -18 M -15.9 M -14.5 M -53.2 M -53.2 M -53.2 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - 8.09 M 6.17 M 1.92 M - 3.54 M 3.59 M 3.34 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-27.8 M -26.9 M - -23.1 M -26.8 M -32 M - -21.1 M -25.4 M -25.4 M - -18 M -18.7 M -16.9 M - -21.2 M -19 M -26.9 M -32.3 M -29.7 M -27 M -30.3 M -22.4 M -19.2 M -18.2 M -16 M -15.2 M -13.7 M -11.9 M -14.1 M - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

88 K 95 K - 278 K 111 K 121 K - -13 K -3 K -10 K - - 3 K - - - 1 K 1 K - 56 K 77 K 212 K - 38 K 118 K 31 K - 228 K 504 K 176 K - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - -22.5 M -26.1 M -31.3 M - -20.7 M -24.7 M -24.7 M - -17.3 M -18 M -16.2 M - -20.5 M -17.6 M -25.8 M -32.3 M -29 M -26.3 M -29.7 M -22.4 M -18.6 M -17.9 M -15.7 M -15.2 M -13.6 M -11.8 M -14.1 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

27.8 M 26.9 M - 23.1 M 26.8 M 32 M - 21.1 M 31.6 M 27.3 M - 21.6 M 22.3 M 20.2 M - 21.2 M 19 M 26.9 M 32.3 M 29.7 M 27 M 30.3 M 22.4 M 19.2 M 18.2 M 16 M 15.2 M 13.7 M 11.9 M 14.1 M - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

8.33 M 7.99 M - 6.41 M 7.13 M 7.4 M - 7.13 M 6.85 M 7.35 M - 7.14 M 6.77 M 6.02 M - 5.18 M 5.53 M 5.25 M - 6.92 M 5.36 M 7.03 M - 4.47 M 4.58 M 4.04 M - 3.08 M 3.28 M 5.38 M - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency